Access Toxo IgM II
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii. 510(k) K242095, from Beckman Coulter, Inc. (Chaska, MN). Product code LGD, class 2.
As of Nov 21, 2026, K242095 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Oct 11, 2024 after 86 days, with no recalls tied to it in FDA's recall database.
- Review time: 86 days
- Recalls: 0
The Access Toxo IgM II assay is a paramagnetic-particle chemiluminescent immunoassay for the qualitative detection of Toxoplasma gondii-specific IgM antibody in adult human serum and plasma using the Access Immunoassay Systems. The Access Toxo IgM II assay is presumptive for the diagnosis of acute, recent, or reactivated Toxoplasma gondii infection in males and pregnant or non-pregnant females.
- Access Toxo Igm Ii Reagents for Use On The Access Immunoassay Systems, Model 34470,34475,34479K003259 · Beckman Coulter, Inc. · Jun 13, 2001
- Access Toxo IgGK242022 · Beckman Coulter, Inc. · Mar 28, 2025
- Alinity i Toxo IgMK233932 · Abbott Laboratories · Aug 30, 2024
- ARCHITECT Toxo IgGK210596 · Abbott Laboratories · May 19, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 17, 2024
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3780
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files